Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -27.70% | 36.76% | -68.59% | -18.38% | -126.01% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | -25.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 281.01% | -91.24% | 91.81% | 73.11% | 266.06% |
| Change in Net Operating Assets | 40.12% | 154.08% | 551.75% | -92.30% | 205.59% |
| Cash from Operations | 828.40% | 94.17% | -1.91% | -505.65% | 153.42% |
| Capital Expenditure | 36.07% | -43.57% | -0.36% | -14.81% | 40.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 36.07% | -43.57% | -0.36% | -14.81% | 40.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 132.01% | 1,497.22% | 85.77% | -- | -- |
| Cash from Financing | 107.84% | 708.96% | -101.92% | 3,889.13% | -174.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,695.95% | 95.74% | -194.19% | 184,200.00% | 100.11% |